文献速递临床免疫质量管理与危急值

PSA回收率异常的发生率与原因

Prevalence and causes of abnormal PSA recovery.
PubMed 文献 · Clin Chem Lab Med · 2018-01-01

该研究通过稀释患者样本并测定PSA回收率,在1158份连续血清样本中发现4份(0.3%)回收率持续异常,其中3份归因于异嗜性抗体,1份归因于抗PSA自身抗体,提示Roche ECLIA法PSA检测可受此类干扰导致结果误判。

要点

  • Roche ECLIA法PSA检测中约0.3%样本回收率异常。
  • 异嗜性抗体和抗PSA自身抗体是回收率异常的主要原因。
  • 回收率异常可导致PSA结果显著失真,需警惕误判。

核心结论

  • Roche ECLIA法PSA测定中约0.3%受异嗜性或抗PSA自身抗体干扰。
  • 此类干扰虽罕见,但可导致PSA结果的显著误判。

研究设计与样本

  • 通过稀释患者样本并加入已知PSA浓度的标准血清测定回收率。
  • 预研究基于268份样本回收率分布,定义回收率<80%或>120%为可疑。
  • 分析1158份连续血清样本,可疑样本复测并进一步鉴定干扰原因。
  • 随访研究检测212份随机血浆样本中的抗PSA自身抗体。

主要发现

  • 1158份样本中4份(0.3%)回收率持续异常,分别为10%、68%、166%和4441%。
  • 3份样本鉴定出异嗜性抗体为可能原因,第4份为抗PSA自身抗体。
  • 抗PSA自身抗体导致的低回收率在6个月后的血清、肝素血浆和EDTA血浆中仍可确认。
  • 8种不同免疫分析法的回收率范围为<10%至80%。
  • 212份随机血浆中7份检出抗PSA自身抗体,但PSA回收率未见异常。

关键数值与推荐

  • 回收率<80%或>120%定义为可疑。
  • 4份异常样本回收率分别为10%、68%、166%和4441%。
  • 8种免疫分析法回收率范围为<10%至80%。

临床怎么用

  • 对PSA结果与临床不符的样本,应考虑异嗜性抗体或抗PSA自身抗体干扰。
  • 可采用稀释回收率试验筛查PSA检测干扰。
  • 怀疑干扰时可更换免疫分析法或进一步鉴定干扰抗体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate-specific antigen (PSA) test is of paramount importance as a diagnostic tool for the detection and monitoring of patients with prostate cancer. In the presence of interfering factors such as heterophilic antibodies or anti-PSA antibodies the PSA test can yield significantly falsified results. The prevalence of these factors is unknown. METHODS: We determined the recovery of PSA concentrations diluting patient samples with a standard serum of known PSA concentration. Based on the frequency distribution of recoveries in a pre-study on 268 samples, samples with recoveries <80% or >120% were defined as suspect, re-tested and further characterized to identify the cause of interference. RESULTS: A total of 1158 consecutive serum samples were analyzed. Four samples (0.3%) showed reproducibly disturbed recoveries of 10%, 68%, 166% and 4441%. In three samples heterophilic antibodies were identified as the probable cause, in the fourth anti-PSA-autoantibodies. The very low recovery caused by the latter interference was confirmed in serum, as well as heparin- and EDTA plasma of blood samples obtained 6 months later. Analysis by eight different immunoassays showed recoveries ranging between <10% and 80%. In a follow-up study of 212 random plasma samples we found seven samples with autoantibodies against PSA which however did not show any disturbed PSA recovery. CONCLUSIONS: About 0.3% of PSA determinations by the electrochemiluminescence assay (ECLIA) of Roche diagnostics are disturbed by heterophilic or anti-PSA autoantibodies. Although they are rare, these interferences can cause relevant misinterpretations of a PSA test result.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lautenbach N, Müntener M, Zanoni P, et al. Prevalence and causes of abnormal PSA recovery. Clin Chem Lab Med. 2018. PMID: 28763294. doi:10.1515/cclm-2017-0246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。